Page 2 - Qazi Corner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qazi corner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qazi Corner Today - Breaking & Trending Today

Taha Qazi, MD: Fenofibrate As First-Line Therapy in Primary Biliary Cholangitis

Qazi discusses a review of the use of fenofibrate as a first-line therapy in treatment-naive patients with PBC and its implications for biochemical response. ....

United States , Taha Qazi , Jeffrey Schwartz , Qazi Corner , American Association , Liver Diseases ,

Gastroenterology Month in Review: December 2023

Our December 2023 Gastroenterology Month in Review features a pair of American Gastroenterological Association guidelines and articles from the fourth installment of Qazi Corner. ....

United States , Katie Falloon , Drug Administration , American College Of Gastroenterology , American Gastroenterological Association , Crohn Disease , Qazi Corner , American College , Recommendations Assessment , Endoscopic Healing Index , Simple Endoscopic Score , Shubha Bhat , Celiac Disease , Crohn X27s Disease , Ulcerative Colitis , Inflammatory Bowel Disease ,

Katie Falloon, MD: SEQUENCE and Treatment Positioning

Katie Falloon, MD, discusses findings from the SEQUENCE study, the importance of treatment positioning, and what direct data from head-to-head studies contributes to this understanding. ....

Katie Falloon , Qazi Corner , Inflammatory Bowel Disease , Crohn X27s Disease ,

Shubha Bhat, PharmD: Understanding Etrasimod for Ulcerative Colitis

Shubha Bhat, PharmD, MS, BCACP describes the ELEVATE UC program supporting the FDA approval of etrasimod and the current understanding of treatment positioning between etrasimod and ozanimod. ....

Drug Administration , Qazi Corner , Shubha Bhat , Sphingosine 1 Phosphate Receptor Modulator , S1p Receptor Modulator , Ulcerative Colitis , Inflammatory Bowel Disease ,

Vonoprazan for the Treatment of Erosive Esophagitis: A Randomized Controlled Trial

While more studies are needed to ensure the safety of long-term therapy with PCABs, this study establishes a role for the use of vonoprazan in the healing and maintenance of healing in patients with erosive esophagitis. ....

Los Angeles , United States , Chiara Maruggi , Los Angeles Classification , Risk Factors , Gastro Oesophageal Reflux Disease , Systematic Review , Gastroesophageal Reflux , Dig Dis , Qazi Corner , Cleveland Clinic , Erosive Esophagitis ,